Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 36 Records) |
| Query Trace: Colorectal Neoplasms and EGF[original query] |
|---|
| [Use of anti-EGFR antibodies (cetuximab and panitumumab) in the treatment of metastatic colorectal cancer in KRAS wild type patients]. Bulletin du cancer 2009 12 96 Suppl S31-40. Smith D, Bosacki C, Merrouche |
| Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer. European journal of cancer (Oxford, England : 1990) 2010 Jul 46 (10): 1829-34. Pander Jan, Gelderblom Hans, Antonini Ninja F, Tol Jolien, van Krieken Johan H J M, van der Straaten Tahar, Punt Cornelis J A, Guchelaar Henk-J |
| Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Sep 17 (17): 5783-92. Gerger Armin, El-Khoueiry Anthony, Zhang Wu, Yang Dongyun, Singh Harpreet, Bohanes Pierre, Ning Yan, Winder Thomas, Labonte Melissa J, Wilson Peter M, Benhaim Leonor, Paez David, El-Khoueiry Rita, Absenger Gudrun, Lenz Heinz-Jos |
| Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Medical oncology (Northwood, London, England) 2012 Jun 29 (2): 1044-9. Daraei A, Salehi R, Salehi M, Emami M H, Janghorbani M, Jonghorbani M, Mohamadhashem F, Tavakoli |
| Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population. International journal of colorectal disease 2011 May . Liou JM, Wu MS, Shun CT, Chiu HM, Chen MJ, Chen CC, Wang HP, Lin JT, Liang JT |
| EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. BMC cancer 2011 11 (1): 107. Spindler Karen-Lise G, Pallisgaard Niels, Lindebjerg Jan, Frifeldt Sanne K, Jakobsen Ande |
| BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer. Cancer genomics & proteomics 0 8 (1): 15-8. Qiu Jinghua, Compagnone Marion, Laibe Sophy, Lagarde Arnaud, Goncalves Anthony, Turrini Olivier, Xerri Luc, Monges Geneviève, Olschwang Sylvia |
| Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer. BMC cancer 2011 Nov 11 (1): 1. Dahan L, Norguet E, Etienne-Grimaldi MC, Formento JL, Gasmi M, Nanni I, Gaudart J, Garcia S, Ouafik L, Seitz JF, Milano G |
| Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls. DNA and cell biology 2012 Apr 31 (4): 568-74. Li Teng-Fei, Ren Ke-Wei, Liu Peng-F |
| The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain. BMC medical genetics 2011 12 (1): 144. Metzger Brigitte, Chambeau Laetitia, Begon Dominique Y, Faber Carlo, Kayser Jacques, Berchem Guy, Pauly Marc, Boniver Jacques, Delvenne Philippe, Dicato Mario, Wenner Thom |
| Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan. British journal of clinical pharmacology 2012 May 73 (5): 776-85. Etienne-Grimaldi Marie-Christine, Bennouna Jaafar, Formento Jean-Louis, Douillard Jean-Yves, Francoual Mireille, Hennebelle Isabelle, Chatelut Etienne, Francois Eric, Faroux Roger, El Hannani Chaza, Jacob Jacques-Henri, Milano Géra |
| KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Nov . Webster J, Kauffman TL, Spencer Feigelson H, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA |
| Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan. The pharmacogenomics journal 2014 Jun 14 (3): 256-62. Sebio A, Páez D, Salazar J, Berenguer-Llergo A, Paré-Brunet L, Lasa A, Del Río E, Tobeña M, Martín-Richard M, Baiget M, Barnadas |
| [Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue]. Harefuah 2013 Jun 152 (6): 326-9, 369. Levi Yosef, Barshack Iris, Avivi Kamila, Bar-ILan Dalia, Gutman Mordechai, Aderka Dan, Berger Raanan, Yacobi Rin |
| Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Aug 19 (15): 4104-13. Smith Christopher G, Fisher David, Claes Bart, Maughan Timothy S, Idziaszczyk Shelley, Peuteman Gilian, Harris Rebecca, James Michelle D, Meade Angela, Jasani Bharat, Adams Richard A, Kenny Sarah, Kaplan Richard, Lambrechts Diether, Cheadle Jeremy |
| PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jun 19 (12): 3285-96. Day Fiona L, Jorissen Robert N, Lipton Lara, Mouradov Dmitri, Sakthianandeswaren Anuratha, Christie Michael, Li Shan, Tsui Cary, Tie Jeannie, Desai Jayesh, Xu Zheng-Zhou, Molloy Peter, Whitehall Vicki, Leggett Barbara A, Jones Ian T, McLaughlin Stephen, Ward Robyn L, Hawkins Nicholas J, Ruszkiewicz Andrew R, Moore James, Busam Dana, Zhao Qi, Strausberg Robert L, Gibbs Peter, Sieber Oliver |
| Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. BMC cancer 2013 Feb 13 (1): 1. Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G |
| EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis. Gene 2013 Apr 519 (1): 26-33. Piao Ying, Liu Zhaozhe, Ding Zhenyu, Xu Long, Guo Fang, Sun Qingqing, Xie Xiaodo |
| Correlation between the EGF gene intronic polymorphism, rs2298979, and colorectal cancer. Oncology letters 2013 Oct 6 (4): 1079-1083. Chaleshi Vahid, Haghighi Mahdi Montazer, Savabkar Sanaz, Zali Neda, Vahedi Mohsen, Khanyaghma Mahsa, Javadi Gholam Reza, Asadzade Hamid, Zali Mohammad Re |
| Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Apr 19 (7): 1902-12. Peeters Marc, Oliner Kelly S, Parker Alex, Siena Salvatore, Van Cutsem Eric, Huang Jing, Humblet Yves, Van Laethem Jean-Luc, André Thierry, Wiezorek Jeffrey, Reese David, Patterson Scott |
| Association between EGF and VEGF functional polymorphisms and sporadic colorectal cancer in the Malaysian population. Genetics and molecular research : GMR 2014 13 (3): 5555-61. Lau T P, Roslani A C, Lian L H, Lee P C, Hilmi I, Goh K L, Chua K |
| The effect of 5'untranslated region polymorphism in EGF gene, rs4444903, on colorectal cancer. Gastroenterology and hepatology from bed to bench 2013 6 (3): 129-35. Chaleshi Vahid, Haghighi Mahdi Montazer, Javadi Gholam Reza, Fatemi Seyed Reza, Vahedi Mohsen, Zali Mohammad Re |
| Polymorphism in epidermal growth factor is related to clinical outcomes of metastatic colorectal cancer patients treated with cetuximab: a systematic review and meta-analysis. International journal of clinical and experimental medicine 2015 8 (7): 10929-37. Lu Xiaoli, Chen Xiaowan, Sun Jingxu, Gao Peng, Song Yongxi, Huang Xuanzhang, Luo Yifan, Chen Ping, Wang Zhenni |
| Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia. Oncotarget 2015 Oct . Wobus Manja, Bornhäuser Martin, Jacobi Angela, Kräter Martin, Otto Oliver, Ortlepp Claudia, Guck Jochen, Ehninger Gerhard, Thiede Christian, Oelschlägel U |
| Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. The pharmacogenomics journal 2016 Nov . Morgen E K, Lenz H-J, Jonker D J, Tu D, Milano G, Graziano F, Zalcberg J, Karapetis C S, Dobrovic A, O'Callaghan C J, Liu |
| Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection Rates. Digestion 2018 Aug 98 (4): 263-269. Koch Christine, Schmidt Niklas, Winkelmann Ria, Eichler Katrin, Pession Ursula, Bechstein Wolf Otto, Zeuzem Stefan, Waidmann Oliver, Trojan Jö |
| The association between EGF A61G polymorphism and risk of colorectal cancer in a Chinese population: a case-control study. Bioscience reports 2019 May . Zhu Xiaoying, Shen Yan, Xie Qig |
| The genetic association between EGF A61G polymorphism (rs4444903) and risk of colorectal cancer: An update meta-analysis and trial sequential analysis. Medicine 2019 Jan 98 (2): e14007. Zhu Yi, Chen ZhiHeng, Jiang HongGang, Lu BoH |
| Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review. Pharmacogenomics and personalized medicine 2020 6 13 167-180. Jamshidi Mohammad, Mohammadi Pour Somayeh, Mahmoudian-Sani Mohammad-Re |
| Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer. Journal of gastrointestinal cancer 2020 Nov . Asadian Fatemeh, Ghadyani Mohammadamin, Antikchi Mohamad Hossein, Dastgheib Seyed Alireza, Neamatzadeh Hossein, Sheikhpour Elnaz, Khajehnoori Sahel, Tabei Seyed Sajj |
- Page last reviewed:Feb 1, 2024
- Content source: